Joshi Abhay 4
4 · Revance Therapeutics, Inc. · Filed Feb 19, 2020
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2020-02-15$25.33/sh−3,325$84,222→ 103,186 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock Awards ("RSA's") for 9,617 shares. The RSA's vest in three equal annual installments from February 15, 2017, and February 15, 2019, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The fair market value was determined on February 14, 2020 pursuant to the Plan.